Cutaneous T-Cell Lymphoma (CTCL): Illuminating a Brighter Path Forward

Cutaneous T‑cell lymphoma (CTCL) is a rare condition that often raises important questions for patients and families.

In this episode, we sit down with Dr. Stefan Barta, of the University of Pennsylvania, to bring clarity to what CTCL is, how it’s diagnosed, and what patients can expect from staging and treatment. Dr. Barta breaks down the differences between CTCL subtypes, explains why diagnosing someone can take time, and shares the most up-to-date therapies, including skin directed treatments, immunotherapies, and emerging clinical trial options. Most importantly, he offers reassurance for those newly diagnosed: “The future is absolutely bright… there is a lot of hope for our patients with CTCL.”

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

• Cutaneous T-cell lymphoma
• Cutaneous Lymphoma Foundation
• Clinical Trial Support Center

Additional Blood Cancer United Support Resources: 

• Free Nutrition Consultations
• Information Specialists 
• Financial support
• Online Chat
• Free telephone/web patient programs 
• Free booklets 
• Young Adult Resources
• Support groups 
• Caregiver support 
• Caregiver Workbook
• Survivorship Workbook
• Advocacy and Public Policy
• Patient Community
• Mental Health Resources

Episode supported by Kyowa Kirin, Inc. and Cutaneous Lymphoma Foundation.

The post Cutaneous T-Cell Lymphoma (CTCL): Illuminating a Brighter Path Forward first appeared on The Bloodline with Blood Cancer United Podcast.